Update on triple therapy for eradication of Helicobacter pylori: current status of the art

References

• GrahamDYFischbachLHelicobacter pylori treatment in the era of increasing antibiotic resistanceGut20105981143115320525969
   PubMed Web of Science ®Google Scholar
• GisbertJPPajaresRPajaresJMEvolution of Helicobacter pylori therapy from a meta-analytical perspectiveHelicobacter200712Suppl 2505817991177
   PubMed Web of Science ®Google Scholar
• GumurduluYSerinEOzerBLow eradication rate of Helicobacter pylori with triple 7–14 days and quadruple therapy in TurkeyWorld J Gastroenterol200410566867114991935
   PubMed Web of Science ®Google Scholar
• BigardMADelchierJCRiachiGThibaultPBarthelemyPOne-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycinAliment Pharmacol Ther19981243833889690730
   PubMed Web of Science ®Google Scholar
• CianciRMontaltoMPandolfiFGasbarriniGBCammarotaGThird-line rescue therapy for Helicobacter pylori infectionWorld J Gastroenterol200612152313231916688818
   PubMed Web of Science ®Google Scholar
• MégraudFH pylori antibiotic resistance: prevalence, importance, and advances in testingGut20045391374138415306603
   PubMed Web of Science ®Google Scholar
• BytzerPDahlerupJFEriksenJRJarbølDERosenstockSWildtSDanish Society for GastroenterologyDiagnosis and treatment of Helicobacter pylori infectionDan Med Bull2011584C427121466771
   PubMed Web of Science ®Google Scholar
• GisbertJPPajaresJMTreatment of Helicobacter pylori infection: the past and the futureEur J Intern Med201021535735920816583
   PubMed Web of Science ®Google Scholar
• PaoluziOAViscontiEAndreiFTen and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerabilityJ Clin Gastroenterol201044426126620195162
   PubMed Web of Science ®Google Scholar
• MalfertheinerPMegraudFO’MorainCCurrent concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut200756677278117170018
   PubMed Web of Science ®Google Scholar
• De FrancescoVGiorgioFHassanCWorldwide H. pylori antibiotic resistance: a systematic reviewJ Gastrointestin Liver Dis201019440941421188333
   PubMed Web of Science ®Google Scholar
• RimbaraEFischbachLAGrahamDYOptimal therapy for Helicobacter pylori infectionsNat Rev Gastroenterol Hepatol201182798821293508
   PubMed Web of Science ®Google Scholar
• GrahamDYLuHYamaokaYTherapy for Helicobacter pylori infection can be improved: sequential therapy and beyondDrugs200868672573618416582
   PubMed Web of Science ®Google Scholar
• Molina-InfanteJPerez-GallardoBFernandez-BermejoMClinical trial: clarithromycin vs levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradicationAliment Pharmacol Ther201031101077108420180787
   PubMed Web of Science ®Google Scholar
• BerningMKraszSMiehlkeSShould quinolones come first in Helicobacter pylori therapy?Therap Adv Gastroenterol201142103114
   Google Scholar
• ChengHHuFLZhangGXLevofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical studyZhonghua Yi Xue Za Zhi20109027982 Chinese.20356486
   PubMedGoogle Scholar
• AssemMEl AzabGRasheedMAAbdelfatahMShasteryMEfficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter studyEur J Intern Med201021431031420603042
   PubMed Web of Science ®Google Scholar
• LiouJMLinJTChangCYLevofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover designGut201059557257820427390
   PubMed Web of Science ®Google Scholar
• GisbertJPPérez-AisaACastro-FernándezMHelicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillinDig Liver Dis201042428729019632166
   PubMedGoogle Scholar
• FockKMKatelarisPSuganoKSecond Asia-Pacific Consensus Guidelines for Helicobacter pylori infectionJ Gastroenterol Hepatol200924101587160019788600
   PubMed Web of Science ®Google Scholar
• WuDCHsuPITsengHHHelicobacter pylori infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapiesMedicine (Baltimore)201190318018521512411
   PubMed Web of Science ®Google Scholar
• GisbertJP“Rescue” regimens after Helicobacter pylori treatment failureWorld J Gastroenterol200814355385540218803350
   PubMed Web of Science ®Google Scholar
• LeeBHKimNHwangTJBismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in KoreaHelicobacter2010151384520302588
   PubMed Web of Science ®Google Scholar
• O’MorainCBorodyTFarleyAEfficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre studyAliment Pharmacol Ther200317341542012562455
   PubMed Web of Science ®Google Scholar
• LaineLHuntREl-ZimaityHNguyenBOsatoMSpénardJBismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trialAm J Gastroenterol200398356256712650788
   PubMed Web of Science ®Google Scholar
• MalfertheinerPBazzoliFDelchierJCHelicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trialLancet2011377976990591321345487
   PubMed Web of Science ®Google Scholar
• CheyWDWongBCAmerican College of Gastroenterology guideline on the management of Helicobacter pylori infectionAm J Gastroenterol200710281808182517608775
   PubMed Web of Science ®Google Scholar
• SaadRJSchoenfeldPKimHMCheyWDLevofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysisAm J Gastroenterol2006101348849616542284
   PubMed Web of Science ®Google Scholar
• GisbertJPMorenaFSystematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failureAliment Pharmacol Ther2006231354416393278
   PubMed Web of Science ®Google Scholar
• KuoCHHuHMKuoFCEfficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trialJ Antimicrob Chemother20096351017102419246508
   PubMed Web of Science ®Google Scholar
• WongWMGuQChuKMLansoprazole, levofloxacin and amoxicillin triple therapy vs quadruple therapy as second-line treatment of resistant Helicobacter pylori infectionAliment Pharmacol Ther200623342142716423001
   PubMed Web of Science ®Google Scholar
• PontoneSStandoliMAngeliniRPontonePEfficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practiceDig Liver Dis201042854154320061196
   PubMedGoogle Scholar
• VairaDZulloAVakilNSequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trialAnn Intern Med2007146855656317438314
   PubMed Web of Science ®Google Scholar
• HsuPIWuDCWuJYGrahamDYIs there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?Helicobacter201116214615221435093
   PubMed Web of Science ®Google Scholar
• SirimontapornNThong-NgamDTumwasornSMahachaiVTen-day sequential therapy of Helicobacter pylori infection in ThailandAm J Gastroenterol201010551071107520010919
   PubMed Web of Science ®Google Scholar
• NadirIYonemOOzinYKilicZMSezginOComparison of two different treatment protocols in Helicobacter pylori eradicationSouth Med J2011104210210521206418
   PubMed Web of Science ®Google Scholar
• GaoXZQiaoXLSongWCWangXFLiuFStandard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradicationWorld J Gastroenterol201016344357436220818821
   PubMed Web of Science ®Google Scholar
• GattaLVakilNLeandroGDi MarioFVairaDSequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and childrenAm J Gastroenterol2009104123069307919844205
   PubMed Web of Science ®Google Scholar
• UrgesiRPeleccaGCianciRHelicobacter pylori infection: is sequential therapy superior to standard triple therapy? Single centre Italian study in naïve and non naïve patients to treatmentCan J Gastroenterol201125631531821766091
   PubMed Web of Science ®Google Scholar
• ChoiWHParkDIOhSJEffectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in KoreaKorean J Gastroenterol2008515280284 Korean.18516011
   PubMedGoogle Scholar
• SavarinoVZentilinPPivariMThe impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pyloriAliment Pharmacol Ther200014789390010886045
   PubMed Web of Science ®Google Scholar
• CammarotaGMartinoAPirozziGHigh efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infectionAliment Pharmacol Ther200419778979515043520
   PubMed Web of Science ®Google Scholar
• EssaASKramerJRGrahamDYTreiberGMeta-analysis: four-drug, three-antibiotic, non-bismuth-containing “concomitant therapy” versus triple therapy for Helicobacter pylori eradicationHelicobacter200914210911819298338
   PubMed Web of Science ®Google Scholar
• WuDCHsuPIWuJYSequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infectionClin Gastroenterol Hepatol201081364119804842
   PubMed Web of Science ®Google Scholar
• HsuPIWuDCWuJYGrahamDYModified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 daysHelicobacter201116213914521435092
   PubMed Web of Science ®Google Scholar
• CammarotaGBrancaGArditoFBiofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trialClin Gastroenterol Hepatol20108981782020478402
   PubMed Web of Science ®Google Scholar
• GisbertJPCalvetXBujandaLMarcosSGisbertJLPajaresJM‘Rescue’ therapy with rifabutin after multiple Helicobacter pylori treatment failuresHelicobacter200382909412662375
   PubMed Web of Science ®Google Scholar
• TreiberGAmmonSMalfertheinerPKlotzUImpact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failuresHelicobacter20027422523112165029
   PubMed Web of Science ®Google Scholar
• SzajewskaHHorvathAPiwowarczykAMeta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatmentAliment Pharmacol Ther20103291069107921039671
   PubMed Web of Science ®Google Scholar
• SongMJParkDIParkJHThe effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pyloriHelicobacter201015320621320557362
   PubMed Web of Science ®Google Scholar
• YaşarBAbutEKayadıbıHEfficacy of probiotics in Helicobacter pylori eradication therapyTurk J Gastroenterol201021321221720931422
   PubMed Web of Science ®Google Scholar
• da Silva MedeirosJAGonçalvesTMBoyanovaLEvaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy aloneEur J Clin Microbiol Infect Dis201130455555921207091
   PubMed Web of Science ®Google Scholar